Victory Capital Management
CBAY

Victory Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Victory Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-689,603
Closed -$16.3M – 2603
2023
Q4 		$16.3M Sell
689,603
-347,830
-34% -$6.19M 0.02% 853
2023
Q3 		$15.5M Buy
1,037,433
+988,683
+2,028% +$13.1M 0.02% 849
2023
Q2 		$534K Buy
48,750
+38,673
+384% +$360K ﹤0.01% 1952
2023
Q1 		$87.9K Buy
+10,077
New +$80.7K ﹤0.01% 2376
2021
Q4 		– Sell
-42,448
Closed -$155K – 2871
2021
Q3 		$155K Hold
42,448
– – ﹤0.01% 2567
2021
Q2 		$185K Sell
42,448
-27,994
-40% -$124K ﹤0.01% 2542
2021
Q1 		$320K Sell
70,442
-2,773
-4% -$14.9K ﹤0.01% 2372
2020
Q4 		$420K Buy
73,215
+22,661
+45% +$172K ﹤0.01% 2158
2020
Q3 		$366K Sell
50,554
-22,258
-31% -$119K ﹤0.01% 2086
2020
Q2 		$254K Hold
72,812
– – ﹤0.01% 2231
2020
Q1 		$108K Sell
72,812
-4,166
-5% -$6.99K ﹤0.01% 2301
2019
Q4 		$151K Hold
76,978
– – ﹤0.01% 2390
2019
Q3 		$394K Buy
76,978
+75,700
+5,923% +$458K ﹤0.01% 1975
2019
Q2 		$9K Hold
1,278
– – ﹤0.01% 1813
2019
Q1 		$17K Hold
1,278
– – ﹤0.01% 1750
2018
Q4 		$10K Sell
1,278
-244
-16% -$2.32K ﹤0.01% 1767
2018
Q3 		$17K Buy
1,522
+200
+15% +$2.48K ﹤0.01% 1766
2018
Q2 		$18K Buy
+1,322
New +$16.5K ﹤0.01% 1800

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Victory Capital Management's CBAY Position: Q1 2024 in Review

Victory Capital Management sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 689,603 shares — an estimated $16.3M sold.

Victory Capital Management first reported a position in CBAY in Q2 2018 and held it in 18 quarters. The position peaked at $16.3M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Victory Capital Management reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Victory Capital Management sold 689,603 Cymabay Therapeutics shares in Q1 2024, an estimated $16.3M.
  • Victory Capital Management first reported a position in Cymabay Therapeutics in Q2 2018 and held it in 18 quarters.
  • Victory Capital Management's Cymabay Therapeutics position peaked at $16.3M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Victory Capital Management's 13F filing for Q1 2024, filed 3 May 2024.